What is Kaya Holdings Inc?
, a vertically integrated legal cannabis enterprise, operates psychedelic treatment clinics and medical cannabis dispensaries in the United States.
KAYS · Verdict
Limited reward · high risk
KAYS's standout is volatility; balance sheet and profitability weigh on the picture.
Based on 88% data coverage
KAYS · Verdict
Top decile vs peers
Current ratio 0.01
-29168% net margin · 0% ROE
-14303% free-cash-flow margin
Revenue -80.0% CAGR
Model-based scoring. For information only — not financial advice.
, a vertically integrated legal cannabis enterprise, operates psychedelic treatment clinics and medical cannabis dispensaries in the United States. It produces, distributes, and sells a range of cannabis products, including flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages; and provides medical and recreational cannabis, and cannabidiol products. The company is listed on the OTCQB in USA, operating in the Healthcare sector, with a market capitalisation of 24.03M.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.